Brand dynamics
Group Real-Time Dynamics And Cutting-Edge Information In The Field Of One Health
Health Yuan Awarded for Outstanding Contribution to Epidemic Prevention and Control, Leveraging Strengths in the Pharmaceutical and Health Industry
Published Time：
2020-11-17
On November 16, the "Greater China Best Listed Company 2020" awards ceremony, hosted by Grlogin, was grandly held in Chengdu. Joincare Pharmaceutical Group Industry Co., Ltd. stood out from numerous participating companies after layers of screening and won the "Outstanding Contribution to Epidemic Prevention and Control Award".
The host, Grlogin, is currently a leading global investment research platform in China. It was the first in China to propose the investment concept of "global vision, betting on China." It combines the roles of financial media, financial public relations, research, investment banking, and databases, providing Chinese investors with one-stop services for overseas investment and financing for Chinese companies, including data, market information, news, research, trading, and social networking. According to the organizer, this selection covered all Chinese listed companies listed on the Hong Kong Stock Exchange, Shanghai Stock Exchange, Shenzhen Stock Exchange, and the US stock market. Authoritative representatives from universities, securities firms, and institutions were invited to form an expert review panel, which objectively and comprehensively selected the best listed companies of the year based on value, growth, innovation, social responsibility, and brand influence.
The highlight of this selection—the "Outstanding Contribution to Epidemic Prevention and Control Award"—was determined based on companies' proactive actions and positive responses to the national call during the fight against the COVID-19 epidemic. The final results were obtained through a combination of "expert panel review + big data analysis," aiming to commend listed companies that have made outstanding contributions to fighting the epidemic in the capital market.
Under the leadership of Chairman Zhu Baoguo, Healthy Yuan has been involved in public welfare activities for a long time. Since the outbreak of the COVID-19 epidemic this year, the group has been at the forefront of the fight against the epidemic. The judging committee stated that Healthy Yuan's demonstration of corporate social responsibility in the face of the epidemic was a key factor in its winning the award.
1. To combat the pneumonia epidemic caused by the novel coronavirus, Healthy Yuan and its holding company, Lizhu Pharmaceutical Group Co., Ltd., donated a total of 22 million yuan in January, including 10 million yuan in cash and 12 million yuan in medical supplies;
2. Donated 3230 boxes of American ginseng tea and 1000 boxes of probiotics to the medical staff of Shenzhen Third People's Hospital, totaling 1 million yuan, supporting the prevention and control efforts of Shenzhen's only designated hospital for COVID-19 treatment;
3. During the "war" against the epidemic, Healthy Yuan did not forget about targeted poverty alleviation. The injection of meropenem donated by Healthy Yuan through the China Red Cross Foundation was also delivered to Xianghai Nature Reserve in Tongyu County, Baicheng City, Jilin Province, alleviating the shortage of medical supplies in epidemic prevention and control in this impoverished area.
For many years, Healthy Yuan has actively participated in various charitable causes, donating over 100 million yuan to environmental protection, education, medical care, poverty alleviation, and disaster relief. From the fight against SARS to the Wenchuan earthquake to Typhoon Mangkhut, whenever major natural disasters have struck the country, the group has always been ready to lend a helping hand. During China's fight against the epidemic, the group continued its fine traditions, continuously contributing positive energy to society with a high sense of social responsibility and patriotism!
Quick Navigation
+86 755-33268688 | Service Hotline
Official WeChat Official Account
Copyright © 2025 Joincare Pharmaceutical Group Industry Co., Ltd. ALL Rights Reserve.